Thopte Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 04-07-2024
- Paid Up Capital ₹ 1.00 M
as on 04-07-2024
- Company Age 41 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.10 M
as on 04-07-2024
- Satisfied Charges ₹ 1.91 M
as on 04-07-2024
- Revenue -39.81%
(FY 2022)
- Profit -113.98%
(FY 2022)
- Ebitda -82.58%
(FY 2022)
- Net Worth -14.82%
(FY 2022)
- Total Assets -13.13%
(FY 2022)
About Thopte Biotech
The Corporate was formerly known as Liv In Transfusions Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.10 M. The company has closed loans amounting to ₹1.91 M, as per Ministry of Corporate Affairs (MCA) records.
Omkar Thopte and Sampatrao Thopate serve as directors at the Company.
- CIN/LLPIN
U01403PN1983PTC031003
- Company No.
031003
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Oct 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Thopte Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Omkar Thopte  | Director | 10-Dec-2003 | Current |
| Sampatrao Thopate | Director | 17-Jan-2017 | Current |
Financial Performance of Thopte Biotech.
Thopte Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 39.81% decrease. The company also saw a substantial fall in profitability, with a 113.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thopte Biotech?
In 2021, Thopte Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asian Pacific Superspeciality Hospital And Research Centre Private LimitedActive 1 year 4 monthsOmkar Thopte is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 05 Jul 2013 | ₹9.10 M | Open |
The Maharashtra State Financial Corporation Creation Date: 14 Feb 1985 | ₹1.91 M | Satisfied |
How Many Employees Work at Thopte Biotech?
Unlock and access historical data on people associated with Thopte Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thopte Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thopte Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
